Skip to content

Atypical Hemolytic Uremic Syndrome With Complement Gene Abnormality C5680166

Published: July 22, 2026Updated: August 20, 2026

A rare condition causing damage to small blood vessels, affecting the kidneys and other organs. It leads to low red blood cells and platelet counts. Treatment suppresses the overactive immune response.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
N28.9
ICD-11
GA00.0
Body system
renal
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Severe anemia (hemoglobin <8 g/dL)

!

Acute kidney injury with oliguria

!

Confusion and seizures

Changes in urination or swelling

(renal)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Thrombotic microangiopathy

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Complement C5 Inhibitor Therapy

Monoclonal antibody therapy targeting terminal complement to prevent endothelial damage. This represents the standard of care for aHUS with complement gene abnormalities and has dramatically improved outcomes in this patient population.

medication
2

Renal disease management

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Therapeutic Plasma Exchange

Procedure to remove autoantibodies and replace deficient complement regulatory proteins. Typically performed daily or every other day until hematologic remission is achieved.

procedure

Additional treatment options

Immunosuppressive Agents

Corticosteroids and other immunosuppressants may be used to control complement dysregulation, particularly when antibody-mediated mechanisms are involved.

medication

Comprehensive Laboratory Monitoring

Regular monitoring of hematologic parameters, renal function, and complement activity to assess treatment response and detect relapse early.

monitoring

Kidney-Supportive Nutritional Management

Dietary modifications including controlled protein intake, sodium restriction, and attention to electrolyte balance to support kidney function during recovery.

dietary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Atypical Hemolytic Uremic Syndrome With Complement Gene Abnormality C5680166?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Goodship TH, Cook HT, Fakhouri F, et al. Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2017.

guideline2017
2

Scully MA, Yadava M, Arshad SH. Complement-mediated atypical hemolytic uremic syndrome: a review of genetic abnormalities and current therapeutic options. Hematology. 2020.

review2020
3

Legendre CM, Licht C, Muus P, et al. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med. 2013.

clinical_trial2013
4

Fakhouri F, Zuber J, Frémeaux-Bacchi V. The kidney in complement-mediated renal diseases: focus on atypical hemolytic uremic syndrome. Nephrol Dial Transplant. 2019.

review2019

Medication Comparisons

Compare medications used to treat Atypical Hemolytic Uremic Syndrome With Complement Gene Abnormality C5680166. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy